Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies
Kim Lauper*, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Jacques-Eric Gottenberg, Satoshi Kubo, Merete Lund Hetland, Florenzo Iannone, Eirik K Kristianslund, Tore K Kvien, Galina Lukina, Xavier Mariette, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria J Santos, Yoshiya Tanaka, Carl TuressonDelphine S Courvoisier, Axel Finckh, Cem Gabay
Dive into the research topics of 'Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies'. Together they form a unique fingerprint.